SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-004933
Filing Date
2023-07-14
Accepted
2023-07-14 17:00:23
Documents
15
Period of Report
2023-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 32344
2 OFFER LETTER TO JOHN DAL POGGETTO sonoma_ex1001.htm EX-10.1 21747
3 CONSULTING AGREEMENT sonoma_ex1002.htm EX-10.2 53599
7 GRAPHIC image_002.jpg GRAPHIC 3619
  Complete submission text file 0001683168-23-004933.txt   304968

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20230711.xsd EX-101.SCH 3295
5 XBRL LABEL FILE snoa-20230711_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snoa-20230711_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3299
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 231089680
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences